Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
Authorized on
Authorized
Remaining
Expires
Terms
13-Nov-26
$1.5bn
$1.5bnEST
n/a
New share repurchase program with no expiration date; repurchases may be made through open market purchases or otherwise8-K filed 13-Nov-26
25-Feb-26
$1.5bn
$105m
n/a
On February 25, 2026, our Board of Directors authorized the repurchase of up to $1.5 billion in shares with no expiration date.10-Q filed 27-Oct-26
Open-market repurchases
Repurchased per month, USD (≈ shares × average price)